The Center joined with Avaxia Biologics, a development stage company focusing on oral antibody therapeutics that act locally within the gastrointestinal tract, to host a ribbon cutting ceremony for the company’s new office and lab space in Lexington. The company received $375,000 in early-stage loan financing through the Center’s Accelerator Program in 2010.
State Senator Kenneth Donnelly, State Representative Jay Kaufman, Avaxia Biologics founder & CEO Barbara Fox, Massachusetts Life Sciences Center Vice President for Communications Angus McQuilken, and MassBio Director of Economic Development & Global Affairs Peter Abair officially open Avaxia’s new office and lab space in Lexington. Photo credit: Stanley Rowin, stanstudio.com
